Subscribe To
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant increased in-hospital and one-year survival PRINCETON, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption […] The post CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantati...
Read More
Content Topics
Cytosorb
With
Vivo
Organ
Perfusion
Transforming
Future
Perfusion
Transplantation
Forex
Posted: Sep 11 2023, 15:32
Author Name: forextv
Views: 112556